“MULTIPARAMETRIC FLOW CYTOMETRY REFINES RISK STRATIFICATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS”. Mediterranean Journal of Hematology and Infectious Diseases 15, no. 1 (August 29, 2023): e2023047. Accessed April 18, 2026. https://www.mjhid.org/mjhid/article/view/5381.